Company: XERI
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001477932-25-003761
Chunk: 47

Company: XERIANT, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 47
---
044,644  $4,450  $51,950  $20,110,352  $(25,171,734) $(2,842,928) $(7,847,893)                                             Conversion of Series A Preferred to Common Stock  (10,000)  -   -   -   10,000,000   100   -   (100)  -   -   -                                              Warrants issued with convertible debt      -   -   -   -   -       66,660   -   -   66,660                                              Net loss  -   -   -   -   -   -   -   -   (376,327)  (7,769)  (384,096)                                             Balance March 31, 2024  723,895  $7   1,000,000  $10   455,044,644  $4,550  $51,950  $20,176,912  $(25,548,061) $(2,850,697) $(8,165,329)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

 F-5Table of Contents

XERIANT, INC.  

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS 

UNAUDITED 

  For the nine months ended   March 31,   2025  2024        Cash Flows from Operating Activities      Net Loss $(1,319,759) $(1,933,003)Adjustments to reconcile net loss to net        cash used by operating activities:        Depreciation and amortization  1,134   1,134 Stock issued for services  282,017   - (Gain) Loss on extinguishment of debt  (60,157)  20,298 Change in fair value of convertible bridge loans  -   2,448 Amortization of debt discount  47,471   2,569 Changes in operating assets and liabilities: